TITLE
Diabetic db/db heart response to rosiglitazone

SUMMARY
Analysis of hearts from obese diabetic C57BL/KsJ-db/db mice following treatment with rosiglitazone, a medication for type 2 diabetes. Results provide insight into the molecular basis of the cardiac decompensation associated with both diabetes and rosiglitazone treatment.

ORGANISM
Mus musculus

